All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC0325 | Human anti-DOCK7 T cell receptor (AD10), pCDTCR1 | AD10 | Human | FLNDLLSVL | HLA-A2 | Lentiviral vector | ||
TCR-YC0326 | Human anti-DOCK7 T cell receptor (BD6), pCDTCR1 | BD6 | Human | FLNDLLSVL | HLA-A2 | Lentiviral vector | ||
TCR-YC0327 | Human anti-DOCK7 T cell receptor (GH4), pCDTCR1 | GH4 | Human | FLNDLLSVL | HLA-A2 | Lentiviral vector | ||
TCR-YC0328 | Human anti-DOCK7 T cell receptor (IA4), pCDTCR1 | IA4 | Human | FLNDLLSVL | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION